PetIQ, Inc. (NASDAQ: PETQ) Stock Competitors & Peer Comparison
See PETQ's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PETQ and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PETQ | $30.98 | -0.03% | 919.2M | 83.73 | $0.37 | N/A |
| TAK | $17.42 | -0.37% | 55.4B | 12.52 | $1.39 | +3.62% |
| HLN | $9.79 | -1.51% | 43.2B | 18.28 | $0.54 | +1.80% |
| TEVA | $37.04 | +1.54% | 42.8B | 12.54 | $2.93 | N/A |
| VTRS | $16.25 | -0.16% | 18.7B | 6.39 | $2.52 | +2.98% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| ELAN | $22.60 | -0.59% | 11.1B | 20.91 | $1.06 | N/A |
| RDY | $12.42 | -0.24% | 10.3B | 20.30 | $0.61 | +0.67% |
| LNTH | $100.90 | +0.22% | 6.6B | 16.93 | $5.95 | N/A |
Stock Comparison
Takeda Pharmaceutical Company Limited (NYSE: TAK)
PETQ vs TAK Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TAK has a market cap of 55.4B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TAK trades at $17.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TAK's P/E ratio is 12.52. In terms of profitability, PETQ's ROE is +0.01%, compared to TAK's ROE of +0.02%. Regarding short-term risk, PETQ is less volatile compared to TAK. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TAK's competition here
Haleon plc (NYSE: HLN)
PETQ vs HLN Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HLN has a market cap of 43.2B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while HLN trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HLN's P/E ratio is 18.28. In terms of profitability, PETQ's ROE is +0.01%, compared to HLN's ROE of +0.17%. Regarding short-term risk, PETQ is less volatile compared to HLN. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check HLN's competition here
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
PETQ vs TEVA Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TEVA has a market cap of 42.8B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TEVA trades at $37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TEVA's P/E ratio is 12.54. In terms of profitability, PETQ's ROE is +0.01%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, PETQ is less volatile compared to TEVA. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TEVA's competition here
Viatris Inc. (NASDAQ: VTRS)
PETQ vs VTRS Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, VTRS has a market cap of 18.7B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while VTRS trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas VTRS's P/E ratio is 6.39. In terms of profitability, PETQ's ROE is +0.01%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, PETQ is less volatile compared to VTRS. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check VTRS's competition here
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
PETQ vs ITCI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ITCI's P/E ratio is -180.64. In terms of profitability, PETQ's ROE is +0.01%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, PETQ is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check ITCI's competition here
Catalent, Inc. (NYSE: CTLT)
PETQ vs CTLT Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CTLT's P/E ratio is -27.84. In terms of profitability, PETQ's ROE is +0.01%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, PETQ is less volatile compared to CTLT. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check CTLT's competition here
Elanco Animal Health Incorporated (NYSE: ELAN)
PETQ vs ELAN Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ELAN has a market cap of 11.1B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ELAN trades at $22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ELAN's P/E ratio is 20.91. In terms of profitability, PETQ's ROE is +0.01%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, PETQ is less volatile compared to ELAN. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ELAN's competition here
Dr. Reddy's Laboratories Limited (NYSE: RDY)
PETQ vs RDY Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RDY has a market cap of 10.3B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while RDY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RDY's P/E ratio is 20.30. In terms of profitability, PETQ's ROE is +0.01%, compared to RDY's ROE of +0.09%. Regarding short-term risk, PETQ is less volatile compared to RDY. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check RDY's competition here
Lantheus Holdings, Inc. (NASDAQ: LNTH)
PETQ vs LNTH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while LNTH trades at $100.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LNTH's P/E ratio is 16.93. In terms of profitability, PETQ's ROE is +0.01%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, PETQ is less volatile compared to LNTH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check LNTH's competition here
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
PETQ vs AMRX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AMRX has a market cap of 5.6B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while AMRX trades at $17.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AMRX's P/E ratio is 19.62. In terms of profitability, PETQ's ROE is +0.01%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, PETQ is less volatile compared to AMRX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check AMRX's competition here
Indivior Pharmaceuticals Inc (NASDAQ: INDV)
PETQ vs INDV Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while INDV trades at $38.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas INDV's P/E ratio is 10.61. In terms of profitability, PETQ's ROE is +0.01%, compared to INDV's ROE of -2.16%. Regarding short-term risk, PETQ is less volatile compared to INDV. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check INDV's competition here
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
PETQ vs SUPN Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SUPN trades at $47.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SUPN's P/E ratio is 15.64. In terms of profitability, PETQ's ROE is +0.01%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, PETQ is less volatile compared to SUPN. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SUPN's competition here
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
PETQ vs RGC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RGC has a market cap of 2.5B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while RGC trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RGC's P/E ratio is -356.34. In terms of profitability, PETQ's ROE is +0.01%, compared to RGC's ROE of -2.32%. Regarding short-term risk, PETQ is less volatile compared to RGC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check RGC's competition here
Bausch Health Companies Inc. (NYSE: BHC)
PETQ vs BHC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while BHC trades at $6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BHC's P/E ratio is 1.58. In terms of profitability, PETQ's ROE is +0.01%, compared to BHC's ROE of +0.89%. Regarding short-term risk, PETQ is less volatile compared to BHC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check BHC's competition here
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
PETQ vs DCPH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DCPH's P/E ratio is -11.58. In terms of profitability, PETQ's ROE is +0.01%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, PETQ is less volatile compared to DCPH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check DCPH's competition here
HUTCHMED (China) Limited (NASDAQ: HCM)
PETQ vs HCM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HCM has a market cap of 2.1B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while HCM trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HCM's P/E ratio is 4.59. In terms of profitability, PETQ's ROE is +0.01%, compared to HCM's ROE of +0.01%. Regarding short-term risk, PETQ is less volatile compared to HCM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check HCM's competition here
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
PETQ vs AVDL Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, PETQ's ROE is +0.01%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, PETQ is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check AVDL's competition here
Embecta Corp. (NASDAQ: EMBCV)
PETQ vs EMBCV Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EMBCV's P/E ratio is N/A. In terms of profitability, PETQ's ROE is +0.01%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, PETQ is less volatile compared to EMBCV. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check EMBCV's competition here
Dynavax Technologies Corporation (NASDAQ: DVAX)
PETQ vs DVAX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DVAX's P/E ratio is -41.89. In terms of profitability, PETQ's ROE is +0.01%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, PETQ is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check DVAX's competition here
Perrigo Company plc (NYSE: PRGO)
PETQ vs PRGO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while PRGO trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PRGO's P/E ratio is 5.07. In terms of profitability, PETQ's ROE is +0.01%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, PETQ is less volatile compared to PRGO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check PRGO's competition here
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
PETQ vs ANIP Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ANIP trades at $75.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ANIP's P/E ratio is 9.14. In terms of profitability, PETQ's ROE is +0.01%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, PETQ is less volatile compared to ANIP. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ANIP's competition here
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
PETQ vs TARO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TARO's P/E ratio is 30.05. In terms of profitability, PETQ's ROE is +0.01%, compared to TARO's ROE of +0.03%. Regarding short-term risk, PETQ is less volatile compared to TARO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TARO's competition here
Harrow Health, Inc. (NASDAQ: HROW)
PETQ vs HROW Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while HROW trades at $39.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HROW's P/E ratio is 437.33. In terms of profitability, PETQ's ROE is +0.01%, compared to HROW's ROE of -1.04%. Regarding short-term risk, PETQ is less volatile compared to HROW. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check HROW's competition here
Phibro Animal Health Corporation (NASDAQ: PAHC)
PETQ vs PAHC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while PAHC trades at $34.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PAHC's P/E ratio is 11.54. In terms of profitability, PETQ's ROE is +0.01%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, PETQ is less volatile compared to PAHC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check PAHC's competition here
Alvotech (NASDAQ: ALVO)
PETQ vs ALVO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ALVO has a market cap of 1.4B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ALVO trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ALVO's P/E ratio is -11.79. In terms of profitability, PETQ's ROE is +0.01%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, PETQ is less volatile compared to ALVO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ALVO's competition here
Cronos Group Inc. (NASDAQ: CRON)
PETQ vs CRON Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CRON trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CRON's P/E ratio is 30.10. In terms of profitability, PETQ's ROE is +0.01%, compared to CRON's ROE of +0.06%. Regarding short-term risk, PETQ is less volatile compared to CRON. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check CRON's competition here
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
PETQ vs ETON Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ETON has a market cap of 1.1B. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ETON trades at $42.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ETON's P/E ratio is -594.00. In terms of profitability, PETQ's ROE is +0.01%, compared to ETON's ROE of -0.06%. Regarding short-term risk, PETQ is less volatile compared to ETON. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ETON's competition here
Pacira BioSciences, Inc. (NASDAQ: PCRX)
PETQ vs PCRX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PCRX has a market cap of 932.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while PCRX trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PCRX's P/E ratio is 9.12. In terms of profitability, PETQ's ROE is +0.01%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, PETQ is less volatile compared to PCRX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check PCRX's competition here
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
PETQ vs AMPH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AMPH has a market cap of 881M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while AMPH trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AMPH's P/E ratio is 6.82. In terms of profitability, PETQ's ROE is +0.01%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, PETQ is less volatile compared to AMPH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check AMPH's competition here
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
PETQ vs COLL Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, COLL has a market cap of 842.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while COLL trades at $28.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas COLL's P/E ratio is 3.26. In terms of profitability, PETQ's ROE is +0.01%, compared to COLL's ROE of +0.16%. Regarding short-term risk, PETQ is less volatile compared to COLL. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check COLL's competition here
Evotec SE (NASDAQ: EVO)
PETQ vs EVO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EVO has a market cap of 778M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while EVO trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EVO's P/E ratio is -3.09. In terms of profitability, PETQ's ROE is +0.01%, compared to EVO's ROE of -0.24%. Regarding short-term risk, PETQ is less volatile compared to EVO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check EVO's competition here
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
PETQ vs IRWD Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while IRWD trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas IRWD's P/E ratio is 5.54. In terms of profitability, PETQ's ROE is +0.01%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, PETQ is less volatile compared to IRWD. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check IRWD's competition here
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
PETQ vs BDSI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BDSI's P/E ratio is 6.82. In terms of profitability, PETQ's ROE is +0.01%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, PETQ is less volatile compared to BDSI. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check BDSI's competition here
Evolus, Inc. (NASDAQ: EOLS)
PETQ vs EOLS Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EOLS has a market cap of 534.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while EOLS trades at $8.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EOLS's P/E ratio is -25.71. In terms of profitability, PETQ's ROE is +0.01%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, PETQ is less volatile compared to EOLS. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check EOLS's competition here
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
PETQ vs AQST Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AQST has a market cap of 530.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while AQST trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AQST's P/E ratio is -6.93. In terms of profitability, PETQ's ROE is +0.01%, compared to AQST's ROE of +2.44%. Regarding short-term risk, PETQ is less volatile compared to AQST. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check AQST's competition here
Tilray Brands, Inc. (NASDAQ: TLRY)
PETQ vs TLRY Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TLRY has a market cap of 523.4M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TLRY trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TLRY's P/E ratio is -4.32. In terms of profitability, PETQ's ROE is +0.01%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, PETQ is less volatile compared to TLRY. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TLRY's competition here
Canopy Growth Corporation (NASDAQ: CGC)
PETQ vs CGC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CGC has a market cap of 432.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CGC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CGC's P/E ratio is -0.62. In terms of profitability, PETQ's ROE is +0.01%, compared to CGC's ROE of -0.33%. Regarding short-term risk, PETQ is less volatile compared to CGC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check CGC's competition here
Kamada Ltd. (NASDAQ: KMDA)
PETQ vs KMDA Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, KMDA has a market cap of 396.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while KMDA trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas KMDA's P/E ratio is 19.66. In terms of profitability, PETQ's ROE is +0.01%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, PETQ is less volatile compared to KMDA. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check KMDA's competition here
Alpha Teknova, Inc. (NASDAQ: TKNO)
PETQ vs TKNO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TKNO has a market cap of 396.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TKNO trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TKNO's P/E ratio is -23.84. In terms of profitability, PETQ's ROE is +0.01%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, PETQ is less volatile compared to TKNO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TKNO's competition here
Alimera Sciences, Inc. (NASDAQ: ALIM)
PETQ vs ALIM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ALIM's P/E ratio is 5.28. In terms of profitability, PETQ's ROE is +0.01%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, PETQ is less volatile compared to ALIM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ALIM's competition here
Embecta Corp. (NASDAQ: EMBC)
PETQ vs EMBC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EMBC has a market cap of 281.8M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while EMBC trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EMBC's P/E ratio is 1.83. In terms of profitability, PETQ's ROE is +0.01%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, PETQ is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check EMBC's competition here
Landec Corporation (NASDAQ: LNDC)
PETQ vs LNDC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LNDC's P/E ratio is -4.04. In terms of profitability, PETQ's ROE is +0.01%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, PETQ is less volatile compared to LNDC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check LNDC's competition here
Aurora Cannabis Inc. (NASDAQ: ACB)
PETQ vs ACB Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ACB has a market cap of 236.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ACB trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ACB's P/E ratio is -7.80. In terms of profitability, PETQ's ROE is +0.01%, compared to ACB's ROE of -0.21%. Regarding short-term risk, PETQ is less volatile compared to ACB. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ACB's competition here
Organogenesis Holdings Inc. (NASDAQ: ORGO)
PETQ vs ORGO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ORGO has a market cap of 232.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ORGO trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ORGO's P/E ratio is 60.33. In terms of profitability, PETQ's ROE is +0.01%, compared to ORGO's ROE of -0.24%. Regarding short-term risk, PETQ is less volatile compared to ORGO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ORGO's competition here
Shineco, Inc. (NASDAQ: TYHT)
PETQ vs TYHT Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TYHT's P/E ratio is -1.61. In terms of profitability, PETQ's ROE is +0.01%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, PETQ is less volatile compared to TYHT. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TYHT's competition here
SIGA Technologies, Inc. (NASDAQ: SIGA)
PETQ vs SIGA Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SIGA has a market cap of 205.8M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SIGA trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SIGA's P/E ratio is 10.63. In terms of profitability, PETQ's ROE is +0.01%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, PETQ is less volatile compared to SIGA. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SIGA's competition here
Organigram Global Inc. (NASDAQ: OGI)
PETQ vs OGI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, OGI has a market cap of 181.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while OGI trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas OGI's P/E ratio is -4.96. In terms of profitability, PETQ's ROE is +0.01%, compared to OGI's ROE of -0.07%. Regarding short-term risk, PETQ is less volatile compared to OGI. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check OGI's competition here
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
PETQ vs LFCR Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LFCR has a market cap of 178.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while LFCR trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LFCR's P/E ratio is -4.46. In terms of profitability, PETQ's ROE is +0.01%, compared to LFCR's ROE of -2.51%. Regarding short-term risk, PETQ is less volatile compared to LFCR. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check LFCR's competition here
Recro Pharma, Inc. (NASDAQ: REPH)
PETQ vs REPH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas REPH's P/E ratio is -8.04. In terms of profitability, PETQ's ROE is +0.01%, compared to REPH's ROE of -0.22%. Regarding short-term risk, PETQ is less volatile compared to REPH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check REPH's competition here
Journey Medical Corporation (NASDAQ: DERM)
PETQ vs DERM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DERM has a market cap of 177M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while DERM trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DERM's P/E ratio is -17.38. In terms of profitability, PETQ's ROE is +0.01%, compared to DERM's ROE of -0.36%. Regarding short-term risk, PETQ is less volatile compared to DERM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check DERM's competition here
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
PETQ vs CRDL Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CRDL has a market cap of 175.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CRDL trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CRDL's P/E ratio is -5.41. In terms of profitability, PETQ's ROE is +0.01%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, PETQ is less volatile compared to CRDL. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check CRDL's competition here
Theratechnologies Inc. (NASDAQ: THTX)
PETQ vs THTX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas THTX's P/E ratio is -28.83. In terms of profitability, PETQ's ROE is +0.01%, compared to THTX's ROE of +0.17%. Regarding short-term risk, PETQ is less volatile compared to THTX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check THTX's competition here
Assertio Holdings, Inc. (NASDAQ: ASRT)
PETQ vs ASRT Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ASRT trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ASRT's P/E ratio is -7.10. In terms of profitability, PETQ's ROE is +0.01%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, PETQ is less volatile compared to ASRT. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ASRT's competition here
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
PETQ vs CPIX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CPIX has a market cap of 119.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CPIX trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CPIX's P/E ratio is -19.90. In terms of profitability, PETQ's ROE is +0.01%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, PETQ is less volatile compared to CPIX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check CPIX's competition here
Societal CDMO, Inc. (NASDAQ: SCTL)
PETQ vs SCTL Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SCTL's P/E ratio is -7.86. In terms of profitability, PETQ's ROE is +0.01%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, PETQ is less volatile compared to SCTL. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SCTL's competition here
BGM Group Ltd. (NASDAQ: BGM)
PETQ vs BGM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BGM has a market cap of 111.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while BGM trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BGM's P/E ratio is -1.01. In terms of profitability, PETQ's ROE is +0.01%, compared to BGM's ROE of -0.07%. Regarding short-term risk, PETQ is less volatile compared to BGM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check BGM's competition here
Procaps Group S.A. (NASDAQ: PROC)
PETQ vs PROC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PROC's P/E ratio is 1.53. In terms of profitability, PETQ's ROE is +0.01%, compared to PROC's ROE of -2.22%. Regarding short-term risk, PETQ is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check PROC's competition here
OptiNose, Inc. (NASDAQ: OPTN)
PETQ vs OPTN Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas OPTN's P/E ratio is -4.42. In terms of profitability, PETQ's ROE is +0.01%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, PETQ is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check OPTN's competition here
Zomedica Corp. (AMEX: ZOM)
PETQ vs ZOM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZOM's P/E ratio is -1.62. In terms of profitability, PETQ's ROE is +0.01%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, PETQ is less volatile compared to ZOM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ZOM's competition here
Upexi, Inc. (NASDAQ: GRVI)
PETQ vs GRVI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas GRVI's P/E ratio is 26.05. In terms of profitability, PETQ's ROE is +0.01%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, PETQ is less volatile compared to GRVI. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check GRVI's competition here
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
PETQ vs ZYBT Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZYBT has a market cap of 73.5M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ZYBT trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZYBT's P/E ratio is -7.05. In terms of profitability, PETQ's ROE is +0.01%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, PETQ is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ZYBT's competition here
Talphera, Inc. (NASDAQ: TLPH)
PETQ vs TLPH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TLPH has a market cap of 72.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TLPH trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TLPH's P/E ratio is -4.52. In terms of profitability, PETQ's ROE is +0.01%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, PETQ is less volatile compared to TLPH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TLPH's competition here
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
PETQ vs ZYNE Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, PETQ's ROE is +0.01%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, PETQ is less volatile compared to ZYNE. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ZYNE's competition here
Silver Spike Investment Corp. (NASDAQ: SSIC)
PETQ vs SSIC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SSIC's P/E ratio is 11.93. In terms of profitability, PETQ's ROE is +0.01%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, PETQ is less volatile compared to SSIC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SSIC's competition here
The Valens Company Inc. (NASDAQ: VLNS)
PETQ vs VLNS Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas VLNS's P/E ratio is -1.03. In terms of profitability, PETQ's ROE is +0.01%, compared to VLNS's ROE of N/A. Regarding short-term risk, PETQ is less volatile compared to VLNS. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check VLNS's competition here
DURECT Corporation (NASDAQ: DRRX)
PETQ vs DRRX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas DRRX's P/E ratio is -4.44. In terms of profitability, PETQ's ROE is +0.01%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, PETQ is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check DRRX's competition here
InterCure Ltd. (NASDAQ: INCR)
PETQ vs INCR Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, INCR has a market cap of 57.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while INCR trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas INCR's P/E ratio is -2.23. In terms of profitability, PETQ's ROE is +0.01%, compared to INCR's ROE of -0.09%. Regarding short-term risk, PETQ is less volatile compared to INCR. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check INCR's competition here
Jupiter Wellness, Inc. (NASDAQ: JUPW)
PETQ vs JUPW Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas JUPW's P/E ratio is -2.41. In terms of profitability, PETQ's ROE is +0.01%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, PETQ is less volatile compared to JUPW. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check JUPW's competition here
China Pharma Holdings, Inc. (AMEX: CPHI)
PETQ vs CPHI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CPHI has a market cap of 44.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CPHI trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CPHI's P/E ratio is -1.72. In terms of profitability, PETQ's ROE is +0.01%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, PETQ is less volatile compared to CPHI. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check CPHI's competition here
Qilian International Holding Group Limited (NASDAQ: QLI)
PETQ vs QLI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas QLI's P/E ratio is -4.92. In terms of profitability, PETQ's ROE is +0.01%, compared to QLI's ROE of -0.16%. Regarding short-term risk, PETQ is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check QLI's competition here
HEXO Corp. (NASDAQ: HEXO)
PETQ vs HEXO Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas HEXO's P/E ratio is -0.26. In terms of profitability, PETQ's ROE is +0.01%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, PETQ is less volatile compared to HEXO. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check HEXO's competition here
Rockwell Medical, Inc. (NASDAQ: RMTI)
PETQ vs RMTI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RMTI has a market cap of 30.8M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while RMTI trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RMTI's P/E ratio is -7.42. In terms of profitability, PETQ's ROE is +0.01%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, PETQ is less volatile compared to RMTI. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check RMTI's competition here
Aytu BioPharma, Inc. (NASDAQ: AYTU)
PETQ vs AYTU Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while AYTU trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AYTU's P/E ratio is -1.23. In terms of profitability, PETQ's ROE is +0.01%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, PETQ is less volatile compared to AYTU. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check AYTU's competition here
TherapeuticsMD, Inc. (NASDAQ: TXMD)
PETQ vs TXMD Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, TXMD has a market cap of 24.1M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while TXMD trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas TXMD's P/E ratio is 105.96. In terms of profitability, PETQ's ROE is +0.01%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, PETQ is less volatile compared to TXMD. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check TXMD's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)
PETQ vs CYTH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CYTH's P/E ratio is -0.80. In terms of profitability, PETQ's ROE is +0.01%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, PETQ is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check CYTH's competition here
Evoke Pharma, Inc. (NASDAQ: EVOK)
PETQ vs EVOK Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas EVOK's P/E ratio is -7.97. In terms of profitability, PETQ's ROE is +0.01%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, PETQ is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check EVOK's competition here
Optimi Health Corp. (NASDAQ: OPTH)
PETQ vs OPTH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, OPTH has a market cap of 15.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while OPTH trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas OPTH's P/E ratio is -17.38. In terms of profitability, PETQ's ROE is +0.01%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, PETQ is less volatile compared to OPTH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check OPTH's competition here
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
PETQ vs ACRX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ACRX's P/E ratio is -0.31. In terms of profitability, PETQ's ROE is +0.01%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, PETQ is less volatile compared to ACRX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ACRX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
PETQ vs BFRIW Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, BFRIW has a market cap of 13.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while BFRIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, PETQ's ROE is +0.01%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, PETQ is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
PETQ vs COSM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, COSM has a market cap of 11.7M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while COSM trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas COSM's P/E ratio is -0.29. In terms of profitability, PETQ's ROE is +0.01%, compared to COSM's ROE of -0.96%. Regarding short-term risk, PETQ is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check COSM's competition here
Agile Therapeutics, Inc. (NASDAQ: AGRX)
PETQ vs AGRX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas AGRX's P/E ratio is -0.89. In terms of profitability, PETQ's ROE is +0.01%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, PETQ is less volatile compared to AGRX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check AGRX's competition here
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
PETQ vs NLTX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas NLTX's P/E ratio is -0.28. In terms of profitability, PETQ's ROE is +0.01%, compared to NLTX's ROE of -0.45%. Regarding short-term risk, PETQ is less volatile compared to NLTX. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check NLTX's competition here
Lannett Company, Inc. (NYSE: LCI)
PETQ vs LCI Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas LCI's P/E ratio is -0.04. In terms of profitability, PETQ's ROE is +0.01%, compared to LCI's ROE of +1.66%. Regarding short-term risk, PETQ is less volatile compared to LCI. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check LCI's competition here
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
PETQ vs ADMP Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ADMP's P/E ratio is -0.08. In terms of profitability, PETQ's ROE is +0.01%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, PETQ is less volatile compared to ADMP. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check ADMP's competition here
cbdMD, Inc. (AMEX: YCBD)
PETQ vs YCBD Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, YCBD has a market cap of 6.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while YCBD trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas YCBD's P/E ratio is -1.49. In terms of profitability, PETQ's ROE is +0.01%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, PETQ is less volatile compared to YCBD. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check YCBD's competition here
Gelteq Limited Ordinary Shares (NASDAQ: GELS)
PETQ vs GELS Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, GELS has a market cap of 5.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while GELS trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas GELS's P/E ratio is -1.14. In terms of profitability, PETQ's ROE is +0.01%, compared to GELS's ROE of -0.25%. Regarding short-term risk, PETQ is less volatile compared to GELS. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check GELS's competition here
Mallinckrodt plc (AMEX: MNK)
PETQ vs MNK Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas MNK's P/E ratio is -0.44. In terms of profitability, PETQ's ROE is +0.01%, compared to MNK's ROE of -0.36%. Regarding short-term risk, PETQ is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check MNK's competition here
Flora Growth Corp. (NASDAQ: FLGC)
PETQ vs FLGC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas FLGC's P/E ratio is -0.19. In terms of profitability, PETQ's ROE is +0.01%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, PETQ is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check FLGC's competition here
Universe Pharmaceuticals Inc. (NASDAQ: UPC)
PETQ vs UPC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, UPC has a market cap of 3.8M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while UPC trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas UPC's P/E ratio is -0.75. In terms of profitability, PETQ's ROE is +0.01%, compared to UPC's ROE of -0.03%. Regarding short-term risk, PETQ is less volatile compared to UPC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check UPC's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
PETQ vs SBFM Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SBFM trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SBFM's P/E ratio is -0.20. In terms of profitability, PETQ's ROE is +0.01%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, PETQ is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SBFM's competition here
PLx Pharma Inc. (NASDAQ: PLXP)
PETQ vs PLXP Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PLXP's P/E ratio is -0.22. In terms of profitability, PETQ's ROE is +0.01%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, PETQ is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check PLXP's competition here
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH)
PETQ vs SHPH Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SHPH has a market cap of 2.5M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SHPH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SHPH's P/E ratio is -0.20. In terms of profitability, PETQ's ROE is +0.01%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, PETQ is less volatile compared to SHPH. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SHPH's competition here
Athenex, Inc. (NASDAQ: ATNX)
PETQ vs ATNX Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas ATNX's P/E ratio is -0.02. In terms of profitability, PETQ's ROE is +0.01%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, PETQ is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check ATNX's competition here
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
PETQ vs SNOA Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SNOA has a market cap of 2.3M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SNOA trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SNOA's P/E ratio is -1.16. In terms of profitability, PETQ's ROE is +0.01%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, PETQ is less volatile compared to SNOA. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SNOA's competition here
Procaps Group, S.A. (NASDAQ: PROCW)
PETQ vs PROCW Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while PROCW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas PROCW's P/E ratio is N/A. In terms of profitability, PETQ's ROE is +0.01%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, PETQ is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check PROCW's competition here
RedHill Biopharma Ltd. (NASDAQ: RDHL)
PETQ vs RDHL Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while RDHL trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas RDHL's P/E ratio is 0.12. In terms of profitability, PETQ's ROE is +0.01%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, PETQ is less volatile compared to RDHL. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check RDHL's competition here
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
PETQ vs SXTC Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, SXTC has a market cap of 1.8M. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while SXTC trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas SXTC's P/E ratio is 1.18. In terms of profitability, PETQ's ROE is +0.01%, compared to SXTC's ROE of -0.31%. Regarding short-term risk, PETQ is less volatile compared to SXTC. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check SXTC's competition here
cbdMD, Inc. (AMEX: YCBD-PA)
PETQ vs YCBD-PA Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, YCBD-PA has a market cap of 928.2K. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while YCBD-PA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas YCBD-PA's P/E ratio is -2.69. In terms of profitability, PETQ's ROE is +0.01%, compared to YCBD-PA's ROE of -0.34%. Regarding short-term risk, PETQ is less volatile compared to YCBD-PA. This indicates lower risk in terms of short-term price fluctuations for PETQ.Check YCBD-PA's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTHW)
PETQ vs CYTHW Comparison August 2026
PetIQ, Inc. (NASDAQ: PETQ) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PETQ stands at 919.2M. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, PETQ is priced at $30.98 on the NASDAQ, while CYTHW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PETQ currently has a P/E ratio of 83.73, whereas CYTHW's P/E ratio is N/A. In terms of profitability, PETQ's ROE is +0.01%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, PETQ is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for PETQ.Check CYTHW's competition here